Lymph node removal range for advanced stomach cancer
Part of Cancer, Digestive system clinical trials.
This study is looking at how far surgeons should remove lymph nodes during surgery for advanced stomach cancer. It may help doctors decide the best way to remove cancer while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have stomach cancer that has been confirmed by a biopsy.
- You are scheduled for a type of stomach surgery called laparoscopic distal subtotal gastrectomy, and the surgeon plans to remove nearby lymph nodes.
- Your cancer is at a stage where it has grown into the stomach wall (T2 to T4a) but has not spread to distant organs.
- You have not had chemotherapy or radiation therapy before.
- You are in generally good health, with no major uncontrolled heart, liver, kidney, or lung problems, and you can care for most of your daily needs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a minimally invasive camera-guided surgical procedure (laparoscopy) can better detect hidden cancer spread in patients with advanced stomach cancer. The goal is to help doctors plan the best treatment and improve outcomes.
This trial is testing a new surgical technique to remove the entire stomach using small incisions (laparoscopy). The goal is to see if this method is safe and feasible for patients with stomach cancer that hasn't spread, potentially offering a less invasive option.
This trial tests a new image-guided method to find and remove sentinel lymph nodes (the first nodes where cancer might spread) in people with early stomach cancer. The goal is to precisely remove only the affected lymph nodes during surgery, which might mean a less extensive operation and fewer side effects.
This trial studies whether removing all of the fatty lining (omentum) or only part of it during surgery leads to better outcomes in people with advanced stomach cancer. It also checks that participants can safely have the same stomach-cancer chemotherapy plan after surgery.
This trial tests a combination of two surgical techniques for early-stage stomach cancer. It aims to remove the tumor and check nearby lymph nodes more precisely, which may help guide treatment and reduce side effects.
This trial compares two different extents of lymph node removal during surgery for advanced right-sided colon cancer, to see which approach is safer and more effective. It aims to help guide surgical decisions.
Hear when a new Gastric Cancer (GC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.